LeMaitre Vascular Inc (NASDAQ:LMAT) has earned a consensus rating of “Buy” from the eight ratings firms that are covering the firm, Marketbeat.com reports. Four equities research analysts have rat
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 13.) Chembio...
BURLINGTON, Mass., April 13, 2020 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, announced today Q1 2020 preliminary,.
BURLINGTON, Mass., April 13, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services,...
Man Group plc acquired a new stake in LeMaitre Vascular Inc (NASDAQ:LMAT) in the fourth quarter, according to its most recent filing with the SEC. The fund acquired 6,136 shares of the medical instrum
Goldman Sachs Group Inc. increased its stake in LeMaitre Vascular Inc (NASDAQ:LMAT) by 311.7% in the 4th quarter, HoldingsChannel reports. The fund owned 82,717 shares of the medical instruments suppl
Bank of New York Mellon Corp reduced its stake in shares of LeMaitre Vascular Inc (NASDAQ:LMAT) by 3.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The

CrowdStrike- Efficiency in the Cloud

10:00am, Friday, 10'th Apr 2020
CrowdStrike (CRWD) is an early stage growth stocks that look promising now, suggests Tyler Laundon, small cap expert and editor of Cabot Early Opportunities.
In 1992 George LeMaitre was appointed CEO of LeMaitre Vascular, Inc. (NASDAQ:LMAT). This report will, first, examine...
In a report released today, James Sidoti from Sidoti maintained a Buy rating on Lemaitre Vascular (LMAT), with a price target of $34.00. The company's
LeMaitre Vascular (NASDAQ:LMAT) had its target price decreased by research analysts at Lake Street Capital from $40.00 to $28.00 in a report issued on Monday, The Fly reports. The firm presently has a
Could LeMaitre Vascular, Inc. (NASDAQ:LMAT) be an attractive dividend share to own for the long haul? Investors are...
Credit Suisse AG lessened its position in LeMaitre Vascular Inc (NASDAQ:LMAT) by 7.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 12,
AQR Capital Management LLC lowered its stake in LeMaitre Vascular Inc (NASDAQ:LMAT) by 12.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 36,254 shares of the m
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE